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Abstract
It is well known that oxidative stress is an inevitable event in aerobic life. When our cells use oxygen to create energy, a variety of re-
active oxygen (ROS) and nitrogen species (RNS) are generated. These species could attack DNA directly and form mutagenic lesions af-
terwards. According to the oxidative stress hypothesis of aging, the oxidative damage to critical molecules accumulates over the life period 
and could ultimately impair the body’s function. Moreover, severe oxidative stress causes mutations of tumor suppressor genes, known as 
one of the initial events in carcinogenesis. Furthermore, it could also play a crucial role in the promotion of the multi-step carcinogenesis. 
On the other hand, the human body possesses a number of mechanisms that counteract oxidative stress by producing antioxidants in situ, or 
externally supplied them through foods and/or supplements. Indeed, a considerable amount of laboratory evidence from chemical, cell cul-
ture, and animal studies indicates that antioxidants may slow down or possibly prevent the cancer development. Yet, the information from 
recent cohort, case-control and/or ecological studies is less clear. Therefore, the objectives of this review are to compile a compendium of 
studies, and to identify effective and promising natural antioxidant interventions.
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Introduction
It is well known that oxidative stress is an inevitable 
event in aerobic life. When our cells use oxygen to cre-
ate energy, a variety of reactive oxygen (ROS) and nitro-
gen species (RNS) are generated as a consequence of ATP 
(adenosine triphosphate) production by the mitochondria 
(Bahorun et al., 2006; Halliwell and Gutteridge, 2007). 
These reactive species could damage the cell structures, in-
cluding lipids and membranes, proteins and nucleic acids. 
Their destructive effects are balanced by the antioxidant 
action of non-enzymatic antioxidants and antioxidant en-
zymes (Halliwell, 1996). Despite the presence of the cell’s 
defense system, oxidative damage accumulates during the 
life period. Moreover, this radical-related damage to DNA, 
to proteins and to lipids could play a crucial role in the de-
velopment of age-dependent diseases such as cancer, arte-
riosclerosis, arthritis, neurodegenerative disorders and oth-
er conditions (Halliwell and Gutteridge, 2007; Pham-Huy, 
2008). According to the oxidative stress hypothesis of ag-
ing, the oxidative damage to critical molecules accumu-
lates over the life period and could ultimately impair the 
body’s function. Moreover, severe oxidative stress causes 
DNA damage and mutations of tumor suppressor genes, 
known as one of the initial events in carcinogenesis (Chat-
terjee et al., 2007; Valko et al., 2006; Valko et al., 2007).
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The human body possesses a number of mechanisms 
that counteract oxidative stress by producing antioxidants. 
They are either produced in situ, or externally supplied 
through foods and/or supplements. The roles of antioxi-
dants are to act as “free radical scavengers” – to prevent 
and/or repair damages caused by ROS and RNS, and ul-
timately to lower the cancer risk (Chatterjee et al., 2007; 
Valko et al., 2006; Valko et al., 2007; Raj et al., 2011).
Endogenous compounds in cells can be classified as 
enzymatic and non-enzymatic antioxidants. The most im-
portant antioxidant enzymes directly involved in the scav-
enging of reactive species are: superoxide dismutase 
(CuZn-SOD, EC 1.15.1.1), catalase (CAT, EC 1.11.1.6), 
and glutathione peroxidase (GPX, EC 1.11.1.9) (Kenneth, 
2003). CuZn-SOD is the first line of defense against free 
radicals, that catalyzes the dismutation of superoxide an-
ion (O2
•ˉ) into hydrogen peroxide (H2O2). The last further 
transforms into water and oxygen (O2) by another enzymes 
such as catalase (CAT) or glutathione peroxidase (GPX). 
The selenoprotein GPX enzyme removes H2O2 and uses 
it to oxidize reduced form of glutathione (GSH) into oxi-
dized glutathione (GSSG). Besides H2O2, GPX also reduc-
es lipid or non-lipid hydroperoxides while oxidizing gluta-
thione (GSH) (Bahorun et al., 2006; Droge, 2002; Genes-
tra, 2007; Halliwell, 2007; Pacher et al., 2007; Willcox et 
al., 2004; Young and Woodside, 2001).
The non-enzymatic antioxidants are divided into met-
abolic and nutrient antioxidants. Metabolic antioxidants, 
such as lipoid acid, glutathione, L-ariginine, coenzyme 
Q10, melatonin, uric acid, bilirubin, metal-chelating pro-
teins, transferrin, etc., are produced by body metabolism 
(Droge, 2002; Willcox et al., 2004). On the contrary, nutri-
ent antioxidants, such as vitamin E, vitamin C, carotenoids, 
trace metals (selenium, manganese, zinc), flavonoids, ome-
ga-3 and omega-6 fatty acids, must be externally supplied 
through foods and/or supplements.
Dietary antioxidants play a key role in helping endog-
enous compounds to combat oxidative stress. They mini-
mize the deleterious effects of free radicals and fight off tu-
mors (Willcox et al., 2004; Donaldson, 2004; Hercberg et 
al., 2010; Riso et al., 2010; Myung et al, 2011). Vegetables, 
fruits, legumes, nuts, and seeds are sources of a variety of 
those bioactive compounds, such as carotenoids (including 
beta-carotene and lycopene), vitamin C, vitamin E, quer-
cetin, and selenium. Experimental evidence indicates a 
strong connection between oxidative damage, cancer, and 
aging. Epidemiological observations suggest that a diet 
rich in fruits and vegetables is associated with lower in-
cidence of some cancers and longer life expectancy; since 
fruits and vegetables contain natural antioxidants, a con-
siderable effort has been dedicated to understanding their 
effects in experimental studies and in human trials (Dolara 
et al., 2012; Somannavar and Kodliwadmath, 2012).
Most cases of cancer (80–90%) are linked to environ-
mental causes, and of these, 30–40% of cancers are linked 
to the diet.  It is believed that most cancers could be pre-
vented by following the recommendations of the 2007 
World Cancer Research Fund/American Institute for Can-
cer Research (WCRF/AICR) Diet and Cancer Report, by 
not smoking, and by avoiding other types of exposure to 
tobacco as well as by following recommendations on the 
subject of diet, physical activity, and weight. (http://www.
aicr.org/research/research_science_expert_report.html). 
Although many dietary recommendations have been pro-
posed to lower the risk of cancer up to date, only few have 
significant supporting scientific evidence. Therefore, the 
objectives of this review are to compile a compendium of 
studies, and to identify effective and promising natural an-
tioxidant interventions.
Natural antioxidants and lung cancer 
Vegetables and lung cancer 
According to the Second Diet and Cancer Report of the 
World Cancer Research Fund/American Institute for Can-
cer Research (WCRF/AICR) there are 17 cohort studies 
of vegetables consumption and lung cancer risk published 
up to date. 14 cohort studies showed reduced risk associ-
ated with higher levels of vegetable consumption (World 
Cancer Research Fund / American Institute for Cancer Re-
search, DC: AICR, 2007). Out of 27 case-control studies 
of total vegetables consumption and risk of lung cancer, 17 
showed reduced risk associated with higher levels of con-
Table 1. Vegetables and lung cancer 
Type of food studied
Cohort Studies Case-Control Studies
Reduced Risk* Total** Reduced Risk* Total**
Total vegetables 14 17 17 27
Non-starchy vegetables 3 3 n/a n/a
Green-leafy vegetables 5 5 12 17
Carrots 6 6 20 21
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
n/a: data not available
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sumption (World Cancer Research Fund / American Insti-
tute for Cancer Research., Washington, DC: AICR, 2007).
Three cohort studies investigated the association be-
tween non-starchy vegetables consumption and lung can-
cer risk and reported non-significant reduced risk when 
comparing highest and lowest vegetable intakes (Jansen 
et al., 2001; Knekt et al., 1997; Kvale et al., 1983). Non-
starchy vegetables are a good source of cancer-preventive 
substances (such as carotenoids and vitamin C, flavonoids, 
allylsulphides, and phytoestrogens). Few possible mecha-
nisms of action are proposed: via their antioxidant activ-
ities, induction of detoxification enzymes, stimulation of 
the immunity, antiproliferative potential, and/or modula-
tion of hormone metabolism. 
Five cohort studies of green, leafy vegetables intake 
and risk of lung cancer reported reduced risk when com-
paring high to low intake groups (Stahelin et al., 1991; 
Steinmetz et al., 1993). 
All six cohort studies of the association between car-
rots consumption and risk of lung cancer published up to 
date reported reduced risk (Speizer et al., 1999). Twenty 
out of the 21 case-control studies showed decreased risk 
when comparing high against low carrots intake groups. 
Carrots contain high levels of carotenoids, mostly al-
pha-carotene and beta-carotene, as well as other vitamins 
with protective effects. Tomatoes are a source of vitamin C 
and carotenoids, mainly lycopene. Suggested mechanisms 
of action of carotenoids include the antioxidant proper-
ties and ligand-dependent signaling via retinoid receptors 
(Shardell et al., 2011). 
Fruits and lung cancer 
According to the Second Diet and Cancer Report of 
the World Cancer Research Fund/American Institute for 
Cancer Research (WCRF/AICR) there is convincing evi-
dence that fruits consumption protect against lung cancer. 
Pooled analysis from 8 cohort studies of fruits intake and 
lung cancer showed a statistically significant reduced risk 
for the highest intake group when compared to the low-
est. Similar results were obtained from the 21 case-control 
studies published up to date. Of the seven ecological stud-
ies, four reported non-significant decreased risk in areas of 
higher fruit consumption, one reported no consistent as-
sociation, and two reported non-significant increased risk. 
A few possible mechanisms are proposed to explain 
the antioxidant properties of fruits. Fruits, in particular cit-
rus fruits, are main sources of vitamin C and flavonoids. 
Vitamin C traps ROS and RNS, protecting against free-
radical damage. It also regenerates other antioxidants such 
as vitamin E (Miller, 2002; Padayatty et al., 2003). Some 
fruits (for instance apples and grapefruit) contain high lev-
els of beta-carotene and other carotenoids, or quercetin and 
other flavonoids. They can further inhibit carcinogen-acti-
vating enzymes and reduce oxidative damage generated by 
inflammation. Furthermore, Liu et al. (2005) reported that 
apples given in physiological quantities inhibited carcino-
gen-induced mammary cancer in rodents.
Dietary quercetin and lung cancer 
According to the WCRF/AICR Diet and Cancer Report 
there is limited evidence suggesting that dietary quercetin 
protects against lung cancer.  In fact, there are only two 
cohort studies that investigated foods containing querce-
tin consumption and lung cancer risk and they showed sig-
nificant decreased risk for the highest intake groups when 
compared to the lowest (Hirvonen et al., 2001; Knekt et 
al., 2002). Two case-control studies showed decreased risk 
for the highest intake groups when compared to the low-
est (statistically significant in one), while one study report-
ed non-significant increased risk (World Cancer Research 
Fund / American Institute for Cancer Research. Washing-
ton, DC: AICR, 2007).
The proposed mechanism of action is that quercetin 
inhibits expression of cytochrome P450 enzyme CYP1A1 
that consequently results in reduced formation of DNA ad-
ducts. Indeed, elevated CYP1A1 activity has been linked 
with increased risk of lung cancer, predominantly in smok-
ers. The protective association of flavonoids is related with 
specific CYP1A1 genotypes; the fact that explains hetero-
geneity of the results (Kang et al., 1999; Le Marchand et 
al., 2000).
Dietary carotenoids and lung cancer 
There is a substantial amount of evidence available 
from both cohort and case-control studies that food con-
taining carotenoids probably protect against lung cancer. 
All 11 cohort studies showed decreased risk for the highest 
intake group, which was statistically significant in three. 
Twelve of the case-control studies showed decreased risk 
for the highest intake group when compared to the low-
est, which was statistically significant in seven. Three stud-
Table 2. Fruits and lung cancer 
Type of food 
studied
Cohort Studies Case-Control Studies Ecological Studies
Reduced Risk* Total** Reduced Risk* Total** Reduced Risk* Total**
Fruits 8 8 21 21 4 7
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
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ies reported increased risk, statistically significant in one, 
while one study reported no effect on risk (World Cancer 
Research Fund / American Institute for Cancer Research. 
DC: AICR, 2007). The similar results were obtained from 
the studies of serum or plasma levels of carotenoids and 
risk of lung cancer - four cohort studies and five case-con-
trol studies reported decreased risk for the highest serum or 
plasma levels when compared to the lowest.
Pooled analysis from 7 cohort studies of dietary beta-
cryptoxanthin consumption and lung cancer risk showed 
a statistically significant decreased risk when comparing 
high against low intake groups (Mannisto et al., 2004). 
On the contrary, the single ecological study reported as-
sociation between increased intake and increased risk (Le 
Marchand et al., 1995).
Interestingly, data on beta-carotene supplements pro-
vide considerable evidence that high-dose supplements 
have a contrasting effect, at least in smokers, increasing 
the risk of lung cancer. Data on dietary beta-carotene (15 
cohort studies, a pooled analysis, 32 case-control studies, 2 
ecological studies) and serum or plasma beta-carotene (13 
cohort studies, 16 case-control studies, 1 ecological study) 
showed no consistent evidence for association (Lin et al., 
2009; Druesne-Pecollo et al., 2010; Jeon et al., 2011).
Dietary selenium and lung cancer 
According to the WCRF/AICR Diet and Cancer Re-
port there is limited evidence to suggest that selenium-
rich foods protect against lung cancer. One cohort study 
showed non-significant increased risk in non-smokers and 
non-significant decreased risk in smokers for the highest 
intake group comparing to the lowest (Schrauzer et al., 
1977). Both case-control studies showed a non-significant 
increased risk for the highest intake group (Cheng et al., 
1996; Hu et al., 1997). Similar results were obtained in the 
studies of plasma or serum selenium and lung cancer - sev-
en cohort studies showed decreased risk for the highest se-
lenium levels, but statistical significance was reached in 
only two of them (Knekt et al., 1998; Salonen et al., 1985). 
Six case-control studies showed decreased risk for the high-
est levels when compared to the lowest. One study inves-
tigated plasma or serum selenium demonstrated non-sig-
nificant increased risk (Tominaga et al., 1992). Two cohort 
studies that investigated selenium levels in nails showed 
decreased risk for the highest selenium levels when com-
pared to the lowest, statistically significant in one (van den 
Brandt et al., 1993; Fritz et al., 2011).
Natural antioxidants and colorectal cancer 
Vegetables and colorectal cancer 
A substantial amount of evidence is available that non-
starchy vegetables protect against colorectal cancer but the 
findings are inconsistent (Papaioannou et al., 2011). 17 co-
hort studies of non-starchy vegetables consumption and 
risk of colorectal cancer reported comparable risk between 
the highest and lowest intake groups, while 11 were in the 
direction of reduced risk (World Cancer Research Fund / 
American Institute for Cancer Research. Washington, DC: 
AICR, 2007).
Additionally, there is consistent evidence, mostly 
from case-control studies, that garlic consumption protects 
against colorectal cancer in a dose-response manner. In-
deed, all six case-control studies showed decreased risk for 
the highest consumers of garlic, statistically significant in 
three (Levi et al., 1999; Yang et al., 1994). Additionally, the 
data obtained from the study with model carcinogens and 
transplantable tumors were in favor of the anticancer effect 
of garlic and some of its allyl sulphur components. Further-
more, the findings from studies with animal models dem-
onstrated that allyl sulphides effectively inhibit tumor for-
mation in the colon (Chu et al., 2007). 
Fruits and colorectal cancer 
There are a number of researchers that studied the asso-
ciation between the fruit consumption and colorectal can-
cer, but the evidence obtained is inconsistent. Twenty co-
hort studies and 57 case-control studies investigated fruits 
and colorectal cancer. Thirteen cohort studies showed de-
creased risk with increased intake, but the statistical sig-
nificance was reached only in two studies (World Cancer 
Research Fund / American Institute for Cancer Research. 
Washington, DC: AICR, 2007).
Table 3. Dietary quercetin, carotenoids, beta-cryptoxanthin and selenium and lung cancer 
Foods containing
Cohort Studies Case-Control Studies
Reduced Risk* Total** Reduced Risk* Total**
Quercetin 2 2 2 3
Carotenoids 11 11 12 16
Beta-cryptoxanthin 7 7 0 1
Selenium 0 1 0 2
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
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Dietary selenium and colorectal cancer 
A substantial amount of data on the association be-
tween dietary selenium and colorectal cancer (although 
from case-control studies only) suggested that selenium-
rich foods protect against colorectal cancer. Fifteen case-
control studies reported decreased risk, statistically sig-
nificant in four (World Cancer Research Fund / American 
Institute for Cancer Research., Washington, DC: AICR, 
2007).
The proposed mechanism of action is that selenium 
deficiency causes a lack of selenoprotein expression. There 
are twenty-five selenoproteins identified up to date; all of 
them having significant anti-inflammatory and antioxidant 
functions. For example, four selenoproteins belong to glu-
tathione peroxidases family; they protect lipids, lipopro-
teins, and DNA from oxidative damage. Three selenopro-
teins are thioredoxin reductases which regenerate oxidized 
ascorbic acid to its active form. All of them are known to 
be rapidly degraded during selenium deficiency. Moreover, 
it was suggested that supraphysiological amounts of sele-
nium could affect programmed cell death, DNA repair, car-
cinogen metabolism, immune system, and anti-angiogenic 
effects (Ganther, 1999; Higdon, et al., 2007).
Natural antioxidants and prostate cancer
Tomatoes, dietary lycopene and prostate cancer 
Lycopene is the most efficient antioxidant among all 
carotenoids identified up to date. It is most bioavailable 
from cooked and pureed tomatoes. Therefore, the best way 
of measuring the systemic exposure is study on tomato 
sauce, or on serum or plasma lycopene. 
There is a substantial amount of consistent evidence, 
from both cohort and case-control studies that lycopene-
containing foods protect against prostate cancer (Seren et 
al., 2008; Vance et al., 2013).
Three of the cohort studies of tomatoes consumption 
and risk of prostate cancer showed decreased risk for the 
highest intake groups when compared to the lowest (Platz 
et al., 2004). Seven of the case-control studies reported de-
creased risk for the highest intake groups when compared 
to the lowest. Two cohort studies of dietary lycopene con-
sumption and prostate cancer reported non-significant de-
creased risk for the highest intake groups when compared 
to the lowest, while the other study showed non-significant 
increased risk. Nine case-control studies showed decreased 
risk for the highest intake groups when compared to the 
lowest, which was statistically significant in one. 
Five cohort studies of serum or plasma lycopene and 
prostate cancer risk reported a non-significant reduced risk 
for the highest intake groups when compared to the low-
est; the other study showed an increased risk (Gann et al., 
1999). Both case-control studies of serum or plasma lyco-
pene showed a statistically significant reduced risk for the 
highest intake groups (Lu et al., 2001; Dahan et al., 2008). 
Dietary beta-carotene and prostate cancer 
In accordance with the evidence from cohort and case-
control studies it could be concluded that foods containing 
beta-carotene does not have a substantial effect on the risk 
of prostate cancer.
Three cohort studies of dietary beta-carotene consump-
tion and prostate cancer showed non-significant increased 
risk with increased intake, while three studies showed no 
effect on risk. Although fourteen case-control studies re-
ported decreased risk with increased intake, statistical sig-
nificance was reached only in two relatively low quality 
studies. The similar findings were obtained from the cohort 
and case-control studies of serum or plasma beta-carotene 
and prostate cancer risk (Vogt et al., 2002).
Dietary vitamin E and prostate cancer 
It is well known that vitamin E slows down DNA dam-
age, increases DNA repair, reduces lipid peroxidation, and 
prevents activation of some carcinogens. Additionally, it 
protects body’s vitamin A and selenium. While acting as a 
free-radical scavenger, it enhances the immune response in 
the body, which may play a crucial role in cancer defenses 
(Willis and Wians, 2003). Vitamin E has also been shown 
to delay the growth of human prostate tumors induced in 
animal models (Fleshner et al., 1999).
Table 4. Natural antioxidants and colorectal cancer 
Foods/
Foods containing
Cohort Studies Case-Control Studies
Reduced Risk* Total** Reduced Risk* Total**
Non-starchy vegetables 11 17 n/a n/a
Garlic n/a n/a 6 6
Fruits 13 20 30 57
Selenium n/a n/a 15 15
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
n/a: data not available
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However, there is limited evidence that vitamin E- rich 
foods protect against prostate cancer. Indeed, the evidence, 
obtained mostly from case-control studies, was inconsis-
tent. For example, statistical significant decreased risk for 
the highest intake groups was demonstrated only in one out 
of seven cohort studies of serum or plasma alpha-tocopher-
ol and prostate cancer (Goodman et al., 2003). Most stud-
ies of dietary vitamin E consumption and prostate cancer 
risk showed non-significant decreased risk, although there 
is heterogeneity in the direction of effect reported and ef-
fect estimates are usually very close to 1 (no effect). All six 
cohort studies that investigated serum gamma-tocopher-
ol and prostate cancer reported inverse association (Wein-
stein et al., 2005; Lin et al., 2009; Klein et al., 2011).
Dietary selenium and prostate cancer 
According to the 2007 WCRF/AICR Diet and Cancer 
Report there is a considerable amount of evidence from 
both cohort and case-control studies, that selenium-rich 
foods protect against prostate cancer. Eight cohort studies 
and four case-control studies reported inverse associations 
between serum or plasma selenium and prostate cancer (Li 
et al., 2004). Two cohort studies of selenium levels in nails 
and prostate cancer risk demonstrated non-significant de-
creased risk for the highest intake groups. Two cohort stud-
ies investigated selenium levels in nails for advanced or 
aggressive prostate cancer. Both showed statistically sig-
nificant decreased risk for the highest intake groups (van 
den Brandt et al., 2003; Klein et al., 2011).
Natural antioxidants and breast cancer
Fruits, vegetables and breast cancer
Some epidemiologic studies suggest that fruit and 
vegetable consumption could reduce risk of breast cancer. 
However, most have been case-control studies in which se-
lection bias may strongly influence the results. In 2000, a 
meta-analysis was performed, aimed to summarize exist-
ing data on the relationship between breast cancer, fruit 
and vegetable consumption and/or the intake of beta-caro-
tene and vitamin C. Relative risks were extracted from 26 
studies published in the period from 1982 to 1997. It con-
firms the association between intake of vegetables and, to 
a lesser extent, fruits and breast cancer risk from published 
sources (Gandini et al., 2000).
Smith-Warner et al. (2001) studied the relation be-
tween breast cancer and total and specific fruit and vegeta-
ble group intakes by means of standardized exposure def-
initions. No associations were found for green leafy vege-
tables, 8 botanical groups, and 17 specific fruits and vege-
tables. Therefore, the results suggest that fruit and vegeta-
ble consumption during adulthood is not significantly as-
sociated with reduced breast cancer risk (Smith-Warner et 
al., 2001).
Riboli and Norat (2003) wanted to summarize evi-
dence from case-control and prospective studies on fruit 
and vegetable consumption and cancer risk with a meta-an-
alytic approach. According to their findings, breast cancer 
is associated with vegetables, but not with fruits consump-
tion (Riboli and Norat, 2003).
Furthermore, of the results from the European Prospec-
tive Investigation into Cancer and Nutrition (EPIC) study 
(the largest study of nutrition and health ever undertaken, 
with over half a million people from ten European coun-
tries enrolled) confirmed that the consumption of fruit and 
vegetables is not associated with breast cancer risk. This 
critical finding helped to narrow down the factors involved 
in breast cancer etiology and prevention (http://epic.iarc.fr/
research/cancer.php). 
Natural antioxidants and stomach cancer
Vegetables and stomach cancer
There are a number of researchers that studied the pos-
sible association between the vegetables consumption and 
stomach cancer. On the basis of a substantial amount of ev-
idence available, including on specific subtypes, particu-
Table 5. Natural antioxidants and prostate cancer 
Type of food stud-
ied
Cohort Studies Case-Control Studies Ecological Studies
Reduced Risk* Total** Reduced Risk* Total** Reduced Risk* Total**
Tomatoes 3 5 7 9 n/a n/a
Lycopene 2 2 9 14 n/a n/a
Beta-carotene 4 10 14 21 n/a n/a
Vitamin E 1 7 n/a n/a n/a n/a
Selenium 1 1 2 7 2 2
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
n/a: data not available
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larly green yellow vegetables, the 2007 WCRF/AICR Diet 
and Cancer Report sums up that vegetables probably pro-
tect against stomach cancer in a dose-response manner. Of 
45 case-control studies that studied non-starchy vegetable 
consumption and stomach cancer, 28 reported statistical-
ly significant decreased risk. Additionally, the majority of 
the 17 remaining studies that reported no significant effect 
on risk were in the direction of decreased risk (Gajalaksh-
mi and Shanta, 1996).
Results from ecological studies on non-starchy vege-
table consumption were inconclusive, with almost as many 
studies reporting increased risk as reported decreased risk 
(Engel et al., 2003). 
Of the 21 case-control studies on green yellow vegeta-
ble consumption and stomach cancer incidence, 16 showed 
decreased risk. This exposure included green-yellow vege-
tables, green vegetables, yellow vegetables, yellow-orange 
vegetables, carrots and pumpkins, and high-carotenoid 
vegetables (Zickute et al., 2005). Nine case-control studies 
that investigated green, leafy vegetables consumption and 
stomach cancer showed decreased risk with increased in-
take (Zickute et al., 2005).
Significant inverse association was found in seven out 
of 12 case-control studies reporting decreased risk with in-
creased intake of lettuce or salad leaves (Ito et al., 2003).
Two cohort studies on tomatoes consumption and 
stomach cancer demonstrated a non-significant increased 
risk with increased intake, while most case-control stud-
ies showed decreased risk with increased intake (Tokui et 
al., 2005). 
One of the proposed mechanisms of action is that bio-
active constituents could protect against H.pylori-induced 
damage, particularly inflammation, the crucial event in the 
development of stomach cancers. It is well known that al-
lium vegetables, especially garlic, are high in flavonols 
and organosulphur compounds. They have antibiotic prop-
erties. Although this may act directly against H pylori, a 
study in humans has not proven this effect. The possible 
mechanism of action is that antibacterial effects of garlic 
might inhibit the colonization of the stomach after H pylo-
ri-induced atrophy. Indeed, a study with animals provided 
evidence that dietary garlic can reduce the severity of H py-
lori-associated gastritis (Iimuro et al., 2002).
According to the findings, allium vegetables-rich diet 
most likely protects against stomach cancer. The data from 
two ecological studies suggested significant decreased in-
cidence of stomach cancer with increased consumption of 
allium vegetables. Similar results were obtained in case 
controls studies that showed reduced risk when comparing 
high with low intake groups (Takezaki et al., 1999). 
Fruits and stomach cancer
On the basis on the substantial amount of evidence on 
association between fruits intake and stomach cancer risk, 
the 2007 WCRF/AICR Diet and Cancer Report summa-
rized that fruits probably protect against stomach cancer in 
a dose-response manner. Forty case-control studies dem-
onstrated decreased risk for the highest intake groups when 
compared to the lowest, being statistically significant in 25 
(López-Carrillo et al., 2004).
Dietary selenium and stomach cancer
There is a substantial amount on the association be-
tween dietary selenium consumption and stomach can-
cer incidence, mostly from case-control studies. However 
there is no strong evidence that selenium-rich foods protect 
Table 6. Natural antioxidants and stomach cancer 
Type of food 
studied
Cohort Studies Case-Control Studies Ecological Studies
Reduced Risk* Total** Reduced Risk* Total** Reduced Risk* Total**
Vegetables n/a n/a 27 45 n/a n/a
Non-starchy 
vegaables
n/a n/a 16 21 n/a n/a
Green, leafy 
vegetables
n/a n/a 9 12 n/a n/a
Letuce n/a n/a 7 12 n/a n/a
Tomato 2 2 n/a n/a n/a n/a
Allium n/a n/a n/a n/a 2 2
Fruits n/a n/a 30 40 n/a n/a
Selenium n/a n/a 0 1 2 2
*Number of the studies that reported reduced cancer risk with higher levels of consumption
**Total number of studies
n/a: data not available
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against stomach cancer onset (Table 6).
The single case-control study that investigated di-
etary selenium consumption and stomach cancer reported 
that dietary selenium was not significantly associated with 
stomach cancer risk, while most ecological studies showed 
that low selenium levels were associated with increased 
stomach cancer risk (World Cancer Research Fund / Amer-
ican Institute for Cancer Research. Food, Washington, DC: 
AICR, 2007).
Conclusion
The implication of oxidative stress in the promotion 
of carcinogenesis suggests that antioxidant therapy repre-
sents a promising opportunity for cancer prevention. Addi-
tionally, a therapeutic strategy to increase the antioxidant 
capacity of cells may be used to fortify the long term ef-
fective treatment. In the past it was generally believed that 
high-dose dietary supplements can modify the risk of some 
cancers. Although some studies in specific, usually high-
risk, groups have shown evidence of cancer prevention 
from some supplements, this finding may not apply to the 
general population. Their level of benefit may be different, 
and there may be unexpected adverse effects. Therefore it 
is unwise to recommend widespread supplement use as a 
means of cancer prevention. 
The 2007 World Cancer Research Fund/American In-
stitute for Cancer Research (WCRF/AICR) Diet and Can-
cer Report strongly recommend that increasing the con-
sumption of the relevant nutrients through the usual diet is 
preferred and the best source of antioxidants is foods and 
drinks, not dietary supplements.
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Резиме
Природните антиоксиданси во превенција на малигни 
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Клучни зборови: оксидативен стрес; реактивни кислородни форми; реактивни азотни форми; природни антиоксиданси; 
канцер.
Оксидативниот стрес е неизбежна последица на аеробниот живот. Во тек на клеточната респирација и продукција 
на високоенергетски соединенија во митохондриите се создава широк спектар на реактивни кислородни (РКФ) и 
азотни форми (РАФ) кои можат директно да ја нападнат молекулата на ДНК. Според теоријата на оксидативен стрес, 
стареењето и дегенеративните болести настануваат како резултат на акумулација на оксидативно оштетување на кри-
тични молекули (ДНК, липиди, протеини) во тек на животниот век. Познато е дека тешкиот оксидативен стрес доведу-
ва мутација на тумор супресорните гени (рани настани во процесот на карциногенеза), но се поврзува и со стадиуми-
те на промоција и прогресија. Човечкиот организам развил одбранбен механизам за заштита од оксидативниот стрес, 
кој го сочинуваат систем на антиоксиданси, создадени in situ или обезбедени преку храна или суплементи. Според 
податоците добиени од студии изведени на клеточни култури или со експериментални животни, антиоксидансите 
можат да го забават, дури и спречат развојот на малигните процеси. Меѓутоа, поновите податоци добиени со анализа 
на изведени кохортни студии, студии на случаи, и/или еколошки студии се контрадикторни. Заради тоа, цел на 
овој преглед е да се резимираат податоците од објавените студии и да се идентификуваат ефективни третмани со 
природни антиоксиданси.

